Voozh

As pharma companies rethink global supply networks, CPHI Americas puts regional resilience, contract manufacturing, and long-term outsourcing partnerships at the center of the conversation.

By: Sara Griffin

VIEW ALL

Free eNewsletter

Subscribe to Magazine for top news, trends & analysis

Contract Services Directory

Browse companies involved in pharmaceutical manufacturing and services.

👁 Image

Analytical Laboratory Services

VIEW ALL

👁 Image

Accelerated Stability Studies

VIEW ALL

👁 Image

ADMET

VIEW ALL

👁 Image

Aerosol Filling

VIEW ALL

Start Searching

VideoBites

👁 CPM_PLD-FEATURE

Reducing Risk in Pharma Product Transfers

Released By PLD Pharma Services

👁 EVOTECH-POSTER

Flexible Innovation for Complex Molecules

Evotec team shares insight on addressing solubility and bioavailability challenges for today’s complex molecules.

Released By EVOTEC

👁 CPM-GLATT_FEATURE

An Inside Look at Integrated Process Solutions at Glatt’s NJ Site

Brian McCollum walks us through Glatt’s capabilities and technologies available at its Ramsey, NJ site from development to commercialization.

Released By Glatt Air Techniques

VIEW ALL

2025 Top 20 Pharma and BioPharma Companies

1

Pfizer
$63.6 Billion

👁 Pfizer

2

Merck
$57.4 Billion

👁 Merck

3

Johnson & Johnson
$57 Billion

👁 Johnson & Johnson

4

Abbvie
$56.3 Billion

👁 Abbvie

5

AstraZeneca
$54.1 Billion

👁 AstraZeneca

6

Roche
$51.1 Billion

👁 Roche

7

Novartis
$50.3 Billion

👁 Novartis

8

Bristol Myers Squibb
$48.3 Billion

👁 Bristol Myers Squibb

9

Lilly
$45 Billion

👁 Lilly

10

Sanofi
$42.8 Billion

👁 Sanofi

VIEW ALL

June 2026

👁 June 2026

Current Issue

FEATURES

Bridging the Gap: The LNP Alliance on Translating Nucleic Acid Therapeutics from Lab to Clinic

Experts from the LNP Alliance discuss where LNP programs stall, how the field is moving beyond vaccines, and why translation requires tighter coordination across formulation, characterization, and preclinical testing.

By: Tim Wright

The Future of Biotech Outsourcing

In this Q&A, Ingenza CEO Nick Challoner, discusses how CRDMOs must evolve to help biotech companies accelerate development, reduce risk, and translate scientific innovation into scalable commercial success.

By: Tim Wright

Cell & Gene Therapy CDMO Partnerships

Alliances and expertise behind advancing CGTs in today’s market.

By: Kristin Brooks

Pharma Matters Q&A

👁 Pharma_Matters_Quotient_Patel_840 x 454

Pharma Matters Q&A

Best Practices for Solving Complex Formulation Challenges While Maintaining Speed Through the Lifecycle

Complex formulations may hold the promise of more targeted therapies, but there are roadbumps to commercialization.

Released By Quotient Sciences

👁 Pharma_Matters_Nelson_Labs_0626_840 x 454

Pharma Matters Q&A

A Guide to Filtration Sterilization, From Microbial Retention Testing to Custom Validations

When sterilization by filtration is appropriate—and ensuring testing necessary to validate it—are important benchmarks.

Released By Nelson Laboratories, LLC

👁 Pharma_Matters_Thermo_Fisher_Kane

Pharma Matters Q&A

Dynamics Reshaping Expectations for CMC Strategy and Execution

As development programs become more complex, sponsors increasingly benefit from a coordinated approach that connects clinical strategy, CMC, manufacturing, and supply planning.

Released By Thermo Fisher Scientific Pharma Services

VIEW ALL

Webinars

👁 Optimizing Plasmid Manufacturing for Cell and Gene Therapy

July 28, 2026

11:00 AM

Optimizing Plasmid Manufacturing for Cell and Gene Therapy

Plasmid DNA is a critical starting material for cell and gene therapies, viral vectors, mRNA therapeutics, and DNA vaccines, but manufacturing it consistently at the required quality and scale can present significant technical and operational challenges.

This webinar will examine key considerations for optimizing plasmid design, process development, production, and analytical control across development stages. Attendees will learn how advanced plasmid engineering, high-performance production strains, scalable purification technologies, and phase-appropriate quality strategies can help improve yield, supercoiling, ITR integrity, and manufacturing timelines.

The session will also explore how an integrated approach spanning plasmid design, CMC development, analytics, and GMP manufacturing can reduce risk and support programs from preclinical development through commercialization.

When Tablets Go Digital: How 3D Printing is Breaking the Rules of Pharma Manufacturing

3D printing is rapidly changing the future of pharmaceutical manufacturing by creating new opportunities in formulation design, drug delivery, and patient focused therapies. Adare’s Giuseppe De Franza, Director, Research and Development Italy, will discuss how 3D screen printing is helping reshape traditional pharmaceutical processes and enabling innovative solutions for complex therapeutic challenges. This webinar will explore the advantages of 3D printing compared to conventional manufacturing methods, including the ability to develop complex drug release profiles and smart drug delivery systems tailored to patient needs. Real world examples featuring Carbidopa/Levodopa applications and gummy delivery systems will highlight how advanced manufacturing technologies are driving flexibility, innovation, and improved patient outcomes.

Reducing Risk and Quality Cost in Supplier Qualification

Learn how to optimize your supplier qualification process while significantly lowering both risk and the total cost of quality. This session examines the true cost of conducting supplier audits and presents practical, proven strategies to reduce it without compromising compliance or patient safety. You will discover the most commonly overlooked audit findings that create hidden compliance and safety risks, along with effective ways to identify and prevent them. The session also evaluates the substantial risks and inefficiencies of traditional manual supplier qualification programs and explores smarter, more efficient alternatives.

Podcasts

👁 Pharma_Matters_Podcast_Veranova_840 x 454

Pharma Matters

When APIs Get More Complex

A closer look at the chemistry, containment, purification, peptide manufacturing, and sustainability challenges shaping modern API development.

Released By Veranova

👁 Pharma_Matters_Podcast_Lifecore_840 x 454

Pharma Matters

An Insider’s Guide to Reaching a Right-the-First-Time Tech Transfer

A closer look at the communication, scale-up, equipment, and collaboration challenges that can make or break a successful tech transfer.

Released By Lifecore Injectables CDMO

👁 Pharma_Matters_Podcast_Gsponer_840 x 454

Pharma Matters

Isoprene — From Vapor to Value

A closer look at how CDMOs safely handle volatile chemistry to transform isoprene into high-value specialty products.

Released By Valsynthese

VIEW ALL

Expert’s Opinion

👁 Untitled design-126

Expert’s Opinion

From Potential to Practical at DIA 2026: A Three-Part Series on Unlocking AI’s Role in Modern Clinical Trials

Part 1 – Simulation in Practice: How AI Is Transforming Trial Design Artificial intelligence has become an integral part of the vision for clinical research and development. The next phase for the industry is translating the progress we’ve made into consistent, scalable and trusted impact. At the 2026 Drug Information Association global meeting, sessions explored what […]

By: Raja Shankar

👁 Screenshot 2026-05-28 at 12.56.08 PM